ISG15 and neoplasm: It seems possible that tumor cells may also adopt different mechanisms to escape the growth inhibitory activities of type I IFNs (e.g. BT474 cells, which do not express detectable ISG15, could have inactivated the IFN signaling pathway through mutations to escape either the immune suppressive or the growth-inhibitory activities of IFNs).